Yani Hu

1PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 28, 2026
Tivozanib versus Sorafenib as Subsequent-Line Therapy for Advanced Renal Cell Carcinoma: A Cost-Effectiveness Analysis from a US Healthcare Perspective.

Pageof 1

Frequent Collaborators

1 joint publications

Xiaoyu Zhang

1 joint publications

Ruming Liu

1 joint publications

Mingdong Yang

1 joint publications

Junjun Xu